¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"È¿"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • concentration effect
    ³óµµÈ¿°ú
  • constitutive enzyme
    ±âº»±¸¼ºÈ¿¼Ò
  • carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼Ò¾ïÁ¦Á¦
  • carboxyltransferase
    Ä«¸£º¹½ÇÀü´ÞÈ¿¼Ò
  • carboxypeptidase
    Ä«¸£º¹½ÃÆéƼµåºÐÇØÈ¿¼Ò
  • convertase
    Àüȯȿ¼Ò
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • cost-effectiveness analysis
    ºñ¿ëÈ¿°úºÐ¼®
  • cost-efficiency analysis
    ºñ¿ëÈ¿À²ºÐ¼®
  • cost-utility analysis
    ºñ¿ëÈ¿¿ëºÐ¼®
  • CPK
    Å©·¹¾ÆÆ¾ÀλêȰ¼ºÈ¿¼Ò
  • creatine kinase isoenzymes
    Å©·¹¾ÆÆ¾Å°³ª¾ÆÁ¦µ¿Á¾È¿¼Ò
  • creatine phosphokinase
    Å©·¹¾ÆÆ¾ÀλêȰ¼ºÈ¿¼Ò
  • cumulative effect
    ´©ÀûÈ¿°ú, ÃàÀûÈ¿°ú
  • curative effect
    Ä¡·áÈ¿°ú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • alkaline phosphatase
    ¾ËÄ®¸®ÀλêºÐÇØÈ¿¼Ò
  • high potency
    °íÈ¿´É, °í¿ª°¡, °íÀáÀç·Â
  • low potency
    ÀúÈ¿´É, Àú¿ª°¡, ÀúÀáÀç·Â
  • RI
    (¢¡ regular insulin) ¼ÓÈ¿Àν¶¸°, ºü¸¥ÀÛ¿ëÀν¶¸°
  • ribonuclease
    ¸®º¸ÇÙ»êºÐÇØÈ¿¼Ò
  • reducase
    ȯ¿øÈ¿¼Ò
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
  • synthetase
    ÇÕ¼ºÈ¿¼Ò
  • physiologic dead space
    »ý¸®¹«È¿°ø°£
  • topoisomerase
    ±¹¼ÒÀ̼ºÈ­È¿¼Ò
  • thromboplastinase
    Æ®·Òº¸ÇÃ¶ó½ºÆ¾ºÐÇØÈ¿¼Ò
  • transferase
    ÀüÀÌÈ¿¼Ò
  • transaminase
    ¾Æ¹Ì³ëÀüÀÌÈ¿¼Ò
  • transcriptase
    Àü»çÈ¿¼Ò
  • telomerase
    ³¡ºÐÀýÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • cavitation effect
    °øµ¿È¿°ú
  • ceiling effect
    ÃÖ°íÈ¿°ú
  • clasp-knife effect
    Á¢´ÂĮȿ°ú
  • clinical efficacy
    ÀÓ»óÈ¿´É
  • coagulase test
    Ç÷ÀåÀÀ°íÈ¿¼Ò°Ë»ç
  • cohort effect
    ÄÚȣƮȿ°ú
  • collection efficiency
    ¼öÁýÈ¿À²
  • collective effective dose
    Áý´ÜÀ¯È¿¼±·®
  • combined effect
    º´¿ëÈ¿°ú
  • combustion efficiency
    ¿¬¼ÒÈ¿À²
  • committed effective dose
    ¿¹Å¹À¯È¿¼±·®
  • concentration effect
    ³óµµÈ¿°ú
  • constitutive enzyme
    ±âº»±¸¼ºÈ¿¼Ò
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • crude efficiency
    Á¶È¿À²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Glycerol ester hydrolase
    ±Û¸®¼¼·Ñ ¿¡½ºÅÍ °¡¼öºÐÇØÈ¿¼Ò(Ê¥â©ÝÂú°ý£áÈ)
  • Glycolytic enzymes
    ÇØ´çÈ¿¼Ò(ú°ÓØý£áÈ)
  • GnRH agonist
    ¼º¼±ÀÚ±ØÈ£¸£¸ó À¯¸® È£¸£¸ó È¿´É¾à
  • H+-K+ ATPase
    ¼ö¼Ò-Ä®·ý ¾Æµ¥³ë½Å»ïÀλêÈ¿¼Ò
  • HIV effect
    HIV È¿°ú<ÀÛ¿ë>
  • Haldane effect
    ÇÒµ§È¿°ú
  • Hemopexin
    Çì¸ðÆå½Å, ÀÀÇ÷È¿¼Ò(ëêúìý£áÈ)
  • Hydrogen-ATP ase mechanism
    ¼ö¼Ò-¾Æµ¥³ë½Å»ïÀλêÈ¿¼Ò ±âÀÛ
  • Hydroxymethylglutary-CoA
    ÇÏÀ̵å·Ï½Ç±Û·çŸ¸°-º¸Á¶È¿¼ÒA
  • Intestinal mucosa, digestive enzymes
    Àå°üÁ¡¸·(íóηïÄØ¯), ¼ÒÈ­È¿¼Ò(á¼ûùý£áÈ)
  • Kovacs oxidase reagent
    Äڹ齺 »êÈ­È¿¼Ò°Ë»ç½Ã¾à
  • LDH = lactic dehydrogenase
    Á¥»ê(¡­ß«) Å»¼ö¼ÒÈ¿¼Ò(÷­â©áÈý£áÈ)
  • LDH= lactic dehydrogenase
    ¶ôÆ®»êÅ»¼ö¼ÒÈ¿¼Ò.
  • Lactase
    ¶ôÅ×ÀÌÁî, À¯´çºÐÇØÈ¿¼Ò(êáÓØÝÂú°ý£áÈ)
  • Lactic acid dehydrogenase
    ¶ôÆ® »êÅ»¼ö¼ÒÈ¿¼Ò(¡­ß«÷­â©áÈý£áÈ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • assay, enzyme-linked immuno(ad)sorbent (ELISA)
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme immunoassay (EIA)
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme linked immunosorbent assay (ELISA)
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme-linked immunosorbent assay
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzymatic zonulysis
    È¿¼Ò¸ð¾çü¼Ò´ëºÐÇØ
  • zymogenesis
    È¿¼Ò¹ß»ý(ý£áÈÛ¡ßæ).
  • zymoplastic
    È¿¼Ò¹ß»ýÀÇ.
  • zymotic disease
    È¿¼Òº´(ý£áÈÜ»)
  • zymotic disease
    È¿¼Òº´(ý£áÈÜ»).
  • enzymopathy
    È¿¼Òº´Áõ.
  • enzymosis
    È¿¼Ò¼º ¹ßÈ¿.
  • fat necrosis,enzymatic
    È¿¼Ò¼º(ý£áÈàõ)
  • enzymatic assay
    È¿¼Ò¼º(ý£áÈàõ) ÃøÁ¤(ö´ïÒ)(¹ý).
  • enzymatic debridement
    È¿¼Ò¼ÒÁ¦¹ý
  • enzymatic assay
    È¿¼Ò¾Æ½êÀ̼º ÃøÁ¤(¹ý).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • assay
    Á¤·®, ¿ª°¡°ËÁ¤, È¿·Â°ËÁ¤
  • assay, enzyme-linked immuno(ad)sorbent (ELISA)
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • aural microphonics
    ÀÌÈ®¼ºÈ¿°ú
  • autofermentation
    ÀÚ°¡¹ßÈ¿.
  • autolytic enzyme
    ÀÚ±âÀ¶ÇØÈ¿¼Ò(¡­ë×ú° ý£áÈ).
  • autolytic enzyme
    ÀÚ°¡¿ëÇØÈ¿¼Ò
  • available
    °¡¿ëÀÇ, À¯È¿ÀÇ.
  • available chlorine
    À¯È¿¿°¼Ò(ËôÌ·ËçËÛ).
  • available phosphoric acid
    À¯È¿Àλê.
  • available water
    À¯È¿¼ö(êóüùâ©).
  • azymia
    ¹«È¿¼Ò(Ùíý£áÈ), È¿¼Ò°á¿©(¡­ÌÀåý).
  • back-pressure effect
    ÈĹæ¾Ð·ÂÈ¿°ú ¡ìÆóÁ¤¸Æ¿ïÇ÷¡í.»ý¸®ÈĹæ¾Ð·ÂÀÛ¿ë(ý­Û°äâæ³íÂéÄ).
  • bacteriostatic effect
    Á¤±ÕÈ¿°ú(¡­üùÍý).
  • beam hardening (effect)
    ºö°æÈ­È¿°ú
  • beam softening (effect)
    ºö¿¬È­È¿°ú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á